Pradaxa 150mg contains dabigatran, an anticoagulant medication designed to prevent blood clots in individuals with specific medical conditions. It works by inhibiting thrombin, a crucial protein in the blood clotting process. Uses Pradaxa 150mg is primarily used to prevent blood clots in patients with atrial fibrillation (irregular heartbeat), deep vein thrombosis (DVT), and pulmonary embolism (PE). It reduces the risk of stroke and systemic embolism in non-valvular atrial fibrillation patients and treats venous thromboembolic events. Benefits Reduces risk of blood clots in at-risk patients Helps prevent complications such as stroke and pulmonary embolism Offers an alternative to traditional anticoagulants like warfarin Does not require routine blood monitoring like some other anticoagulants Predictable anticoagulant effect with fixed dosing Rapid onset and offset of action How It Works Pradaxa functions as a direct thrombin inhibitor. By blocking the action of thrombin, a key enzyme in the coagulation cascade, it prevents the formation of blood clots. This mechanism helps maintain proper blood flow and reduces the risk of thrombotic events without affecting other clotting factors. Dosage Indication Standard Dosage Frequency Atrial Fibrillation 150mg Twice daily DVT/PE Treatment 150mg Twice daily DVT/PE Prevention 150mg Twice daily Take with or without food. Swallow capsules whole with water. Do not open, chew, or crush capsules. Duration of Action Pradaxa 150mg reaches peak plasma concentrations within 1-3 hours after oral administration. Its anticoagulant effect lasts for approximately 12 hours, which is why it’s taken twice daily to maintain consistent therapeutic blood levels and continuous protection against clotting. Side Effects Common side effects include indigestion, stomach pain, nausea, and mild bleeding such as nosebleeds or bruising. Serious side effects, though rare, include major bleeding (including internal bleeding), liver damage, and allergic reactions. Contact healthcare provider immediately if experiencing unusual bleeding or severe symptoms. Warning Patients taking Pradaxa should be monitored regularly for signs of bleeding or other complications. Abrupt discontinuation can increase the risk of blood clots and stroke. Do not stop taking Pradaxa without consulting your doctor. Avoid activities with high risk of injury while on this medication. Pregnancy and Breastfeeding Pradaxa should be used during pregnancy only if potential benefit justifies potential risk to the fetus. It is not known whether Pradaxa is excreted in human milk. Consult healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before taking this medication. Interaction May interact with other blood thinners or NSAIDs, increasing bleeding risk Certain medications may affect the metabolism of Pradaxa Antacids may decrease the effectiveness of this medication P-glycoprotein inhibitors can increase dabigatran levels Rifampin and other strong P-gp inducers may reduce effectiveness Precaution Use with caution in patients with kidney impairment as dosage adjustment may be required. Elderly patients may have increased bleeding risk. Inform all healthcare providers about Pradaxa use before any surgical or dental procedures. Store capsules in original bottle to protect from moisture. Do not remove desiccant from bottle. Important Information Pradaxa is a prescription medication that should only be taken under medical supervision. Regular follow-ups with your healthcare provider are essential to monitor effectiveness and potential side effects. In case of planned surgical procedures, inform your doctor about Pradaxa use, as it may need to be temporarily discontinued to reduce bleeding risk.
